12-100505623-C-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_001206979.2(NR1H4):c.80-5155C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00195 in 701,566 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0019 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0020 ( 2 hom. )
Consequence
NR1H4
NM_001206979.2 intron
NM_001206979.2 intron
Scores
1
14
Clinical Significance
Conservation
PhyloP100: -0.215
Genes affected
NR1H4 (HGNC:7967): (nuclear receptor subfamily 1 group H member 4) This gene encodes a ligand-activated transcription factor that shares structural features in common with nuclear hormone receptor family members. This protein functions as a receptor for bile acids, and when bound to bile acids, binds to DNA and regulates the expression of genes involved in bile acid synthesis and transport. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Feb 2016]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.008201271).
BP6
Variant 12-100505623-C-G is Benign according to our data. Variant chr12-100505623-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 1298553.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00185 (282/152284) while in subpopulation NFE AF = 0.00321 (218/68016). AF 95% confidence interval is 0.00286. There are 1 homozygotes in GnomAd4. There are 114 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position FAILED quality control check.
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00185 AC: 282AN: 152166Hom.: 1 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
282
AN:
152166
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00145 AC: 185AN: 127758 AF XY: 0.00137 show subpopulations
GnomAD2 exomes
AF:
AC:
185
AN:
127758
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00198 AC: 1087AN: 549282Hom.: 2 Cov.: 0 AF XY: 0.00178 AC XY: 530AN XY: 297370 show subpopulations
GnomAD4 exome
AF:
AC:
1087
AN:
549282
Hom.:
Cov.:
0
AF XY:
AC XY:
530
AN XY:
297370
Gnomad4 AFR exome
AF:
AC:
8
AN:
15780
Gnomad4 AMR exome
AF:
AC:
46
AN:
34680
Gnomad4 ASJ exome
AF:
AC:
23
AN:
20000
Gnomad4 EAS exome
AF:
AC:
0
AN:
32064
Gnomad4 SAS exome
AF:
AC:
25
AN:
62584
Gnomad4 FIN exome
AF:
AC:
52
AN:
33170
Gnomad4 NFE exome
AF:
AC:
880
AN:
316414
Gnomad4 Remaining exome
AF:
AC:
48
AN:
30546
Heterozygous variant carriers
0
45
90
135
180
225
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00185 AC: 282AN: 152284Hom.: 1 Cov.: 32 AF XY: 0.00153 AC XY: 114AN XY: 74474 show subpopulations
GnomAD4 genome
AF:
AC:
282
AN:
152284
Hom.:
Cov.:
32
AF XY:
AC XY:
114
AN XY:
74474
Gnomad4 AFR
AF:
AC:
0.000457148
AN:
0.000457148
Gnomad4 AMR
AF:
AC:
0.00117647
AN:
0.00117647
Gnomad4 ASJ
AF:
AC:
0.00201729
AN:
0.00201729
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0.000207383
AN:
0.000207383
Gnomad4 FIN
AF:
AC:
0.00122457
AN:
0.00122457
Gnomad4 NFE
AF:
AC:
0.00320513
AN:
0.00320513
Gnomad4 OTH
AF:
AC:
0.00236518
AN:
0.00236518
Heterozygous variant carriers
0
12
23
35
46
58
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
7
ALSPAC
AF:
AC:
9
ExAC
AF:
AC:
12
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Jun 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
NR1H4: BP4 -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
DANN
Benign
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
.;T
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
PROVEAN
Benign
.;N
REVEL
Benign
Sift
Uncertain
.;D
Sift4G
Benign
.;T
Vest4
0.051
MutPred
Gain of catalytic residue at H40 (P = 0.0158);Gain of catalytic residue at H40 (P = 0.0158);
MVP
0.16
ClinPred
T
GERP RS
Mutation Taster
=100/0
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at